ArticleNeurochemical research2026

Elamipretide (SS-31) and Nicotinamide Mononucleotide (NMN) Combination Therapy Targets TREM2 to Mitigate Post-ischemic Brain Injury in Mice.

Qinghuan Yang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.